{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:44:56Z","timestamp":1767181496451,"version":"build-2238731810"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161209","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T16:04:02Z","timestamp":1471449842000},"page":"e0161209","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-\u03b2 Peptides"],"prefix":"10.1371","volume":"11","author":[{"given":"Marie","family":"Hoarau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Malbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Irague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Hureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Faller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Gras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Remaud-Sim\u00e9on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2013.05.010","article-title":"Alzheimer\u2019s disease: review of hormone therapy trials and implications for treatment and prevention after menopause","volume":"142","author":"VW Henderson","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurol.2014.10.003","article-title":"Amyloid beta peptide immunotherapy in Alzheimer disease","volume":"170","author":"J Delrieu","year":"2014","journal-title":"Rev Neurol (Paris)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/emm.2014.124","article-title":"Stem cell therapy for Alzheimer\u2019s disease and related disorders: current status and future perspectives","volume":"47","author":"LM Tong","year":"2015","journal-title":"Exp Mol Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer\u2019s disease: an appraisal from 1984 to 2014","volume":"275","author":"LS Schneider","year":"2014","journal-title":"J Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1111\/febs.12813","article-title":"The coexistence of an equal amount of Alzheimer\u2019s amyloid-\u03b2 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway","volume":"281","author":"Y-J Chang","year":"2014","journal-title":"FEBS J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1021\/cr3000994","article-title":"The Amyloid Beta Peptide: A Chemist\u2019s Perspective. Role in Alzheimer\u2019s and Fibrillization","volume":"112","author":"IW Hamley","year":"2012","journal-title":"Chem Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1021\/acs.biochem.5b00467","article-title":"Mechanism of Nucleated Conformational Conversion of A\u03b242","volume":"54","author":"Z Fu","year":"2015","journal-title":"Biochemistry (Mosc)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(95)12089-M","article-title":"Fibrillogenesis of synthetic amyloid-\u03b2 peptides is dependent on their initial secondary structure","volume":"200","author":"C Soto","year":"1995","journal-title":"Neurosci Lett"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0076-6879(99)09015-1","article-title":"Methodological and chemical factors affecting amyloid \u03b2 peptide amyloidogenicity","author":"MG Zagorski","year":"1999","journal-title":"Methods in Enzymology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmb.2009.12.016","article-title":"The Recombinant Amyloid-\u03b2 Peptide A\u03b21\u201342 Aggregates Faster and Is More Neurotoxic than Synthetic A\u03b21\u201342","volume":"396","author":"VH Finder","year":"2010","journal-title":"J Mol Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pep.2008.09.015","article-title":"Expression, purification and characterization of recombinant human \u03b2-amyloid 1\u201342 in Pichia pastoris","volume":"63","author":"M Shen","year":"2009","journal-title":"Protein Expr Purif"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/bip.21391","article-title":"Novel semisynthetic method for generating full length \u03b2-amyloid peptides","volume":"94","author":"JJ Bockhorn","year":"2010","journal-title":"Biopolymers"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pep.2004.12.014","article-title":"Production of recombinant amyloid-\u03b2 peptide 42 as an ubiquitin extension","volume":"40","author":"EK Lee","year":"2005","journal-title":"Protein Expr Purif"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pep.2009.02.009","article-title":"Expression and purification of amyloid-\u03b2 peptides from Escherichia coli","volume":"66","author":"K Garai","year":"2009","journal-title":"Protein Expr Purif"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1021\/ic300972j","article-title":"Insights into the Mechanisms of Amyloid Formation of Zn <sup>II<\/sup> -Ab11-28: pH-Dependent Zinc Coordination and Overall Charge as Key Parameters for Kinetics and the Structure of Zn <sup>II<\/sup> -Ab11-28 Aggregates","volume":"51","author":"B Alies","year":"2012","journal-title":"Inorg Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"14673","DOI":"10.1021\/jacs.5b07849","article-title":"N-Terminal Extensions Retard A\u03b242 Fibril Formation but Allow Cross-Seeding and Coaggregation with A\u03b242","volume":"137","author":"O Szczepankiewicz","year":"2015","journal-title":"J Am Chem Soc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2015.05.002","article-title":"A novel method for expression and purification of authentic amyloid-\u03b2 with and without 15N labels","volume":"113","author":"Y-H Liao","year":"2015","journal-title":"Protein Expr Purif"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jchromb.2007.06.003","article-title":"Purification of recombinantly expressed and cytotoxic human amyloid-beta peptide 1\u201342","volume":"856","author":"K Wiesehan","year":"2007","journal-title":"J Chromatogr B"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pep.2015.07.012","article-title":"A facile method for expression and purification of 15N isotope-labeled human Alzheimer\u2019s \u03b2-amyloid peptides from E. coli for NMR-based structural analysis","volume":"116","author":"SC Sharma","year":"2015","journal-title":"Protein Expr Purif"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pep.2015.05.015","article-title":"An improved method for high-level soluble expression and purification of recombinant amyloid-beta peptide for in vitro studies","volume":"114","author":"G Chhetri","year":"2015","journal-title":"Protein Expr Purif"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","article-title":"A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid \u03b2-peptide: Expression and purification of the amyloid \u03b2-peptide","volume":"276","author":"DM Walsh","year":"2009","journal-title":"FEBS J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1039\/c2mb25214g","article-title":"Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation","volume":"8","author":"A Espargar\u00f3","year":"2012","journal-title":"Mol Biosyst"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2014.04.049","article-title":"Soni-removal of nucleic acids from inclusion bodies","volume":"448","author":"M Neerathilingam","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1475-2859-11-55","article-title":"Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors","volume":"11","author":"A Villar-Piqu\u00e9","year":"2012","journal-title":"Microb Cell Factories"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/jb.174.21.6938-6947.1992","article-title":"Two novel heat shock genes encoding proteins produced in response to heterologous protein expression in Escherichia coli","volume":"174","author":"SP Allen","year":"1992","journal-title":"J Bacteriol"},{"key":"ref26","first-page":"319","article-title":"Advances in Protein Chemistry","author":"GH Beaven","year":"1952"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pep.2011.05.012","article-title":"Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer\u2019s \u03b2-amyloid peptide for NMR-based structural analysis","volume":"79","author":"F Long","year":"2011","journal-title":"Protein Expr Purif"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pep.2012.08.021","article-title":"Large-scale production of soluble recombinant amyloid-\u03b2 peptide 1\u201342 using cold-inducible expression system","volume":"86","author":"E-K Kim","year":"2012","journal-title":"Protein Expr Purif"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0205048","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:53:37Z","timestamp":1588985617000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161209"}},"subtitle":[],"editor":[{"given":"Koichi M","family":"Iijima","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161209","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}